Upstaza: First Gene Therapy For Ultra-Rare Disorder AADC Deficiency Receives English Funding
Executive Summary
The single-dose gene therapy for aromatic L-amino acid decarboxylase in children is to be made available on the National Health Service following a confidential commercial deal between NHS England and PTC Therapeutics.